Active substances
Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate
- SFDA 11
- US FDA 12
- Health Canada 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COMPOUND SODIUM LACTATE INF. | 6,0.40,0.27,3.20 g/ml,g/ml,g/ml,g/ml | Solution for infusion · Intravenous use | 1 Bottle | SAR 11.30 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| COMPOUND SODIUM LACTATE INF. | 6,0.40,0.27,3.2 g/ml,g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bottle | SAR 7.70 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| COMPOUND SODIUM LACTATE INF. | 6,0.40,0.27,3.20 g/ml,g/ml,g/ml,g/ml | Solution for infusion · Intravenous use | 1 Bottle | SAR 6.80 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| COMPOUND SODIUM LACTATE INF. | 6,0.40,0.27,3.20 g/ml,g/ml,g/ml,g/ml | Solution for infusion · Intravenous use | 1 Bag | SAR 10.20 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| COMPOUND SODIUM LACTATE INFUSION | 6,0.40,0.27,3.2 g/ml,g/ml,g/ml,g/ml | Solution · Intravenous use | 1 Bag | SAR 16.10 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| DEXTROSE ,RINGER LACTATE | 6,3.2,0.4,0.27 mg/ml,mg/ml,mg/ml,mg/ml | Solution for injection · Intravenous use | 1 Bag | SAR 9.25 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| DEXTROSE ,RINGER LACTATE | 6,3.2,0.4,0.27 mg/ml,mg/ml,mg/ml,mg/ml | Solution for injection · Intravenous use | 1 Bottle | SAR 11.95 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| LACTATED RINGERS INJECTION USP 500 ML | 0.598,0.03,0.02,0.31 %,%,%,% | Solution for injection · Intravenous use | 1 Bottle | SAR 5.45 | Generic · Prescription | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| RINGERS LACTATE SOLU. FOR I.V. INFUSION IN VIAFLEX | 6,3.22,0.4,0.27 g/l,g/l,g/l,g/l | Solution for infusion · Intravenous use | 1 Bag | SAR 5.00 | Generic · Prescription | Baxter Company Limited | Withdrawn by MAH · Not Marketed |
| RINGERS LACTATE SOLU. FOR I.V. INFUSION IN VIAFLEX | 6,3.22,0.4,0.27 g/l,g/l,g/l,g/l | Solution for infusion · Intravenous use | 1 Bag | SAR 6.85 | Generic · Prescription | Baxter Company Limited | Withdrawn by MAH · Not Marketed |
| RINGERS LACTATE SOLU. FOR I.V. INFUSION IN VIAFLEX | 6,3.22,0.4,0.27 g/l,g/l,g/l,g/l | Solution for infusion · Intravenous use | 1 Bag | SAR 11.10 | Generic · Prescription | Baxter Company Limited | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE PANCREATITIS; CENTRAL DIABETES INSIPIDUS; FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | BAXTER HLTHCARE | Prescription | 22 Mar 1971 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | OTSUKA ICU MEDCL | Prescription | 26 Jan 1976 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | solution · irrigation | BAXTER HLTHCARE | Prescription | 19 Feb 1982 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | solution · irrigation | B BRAUN | Prescription | 27 Dec 1982 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | solution · irrigation | BAXTER HLTHCARE | Prescription | 3 Apr 1984 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | solution · irrigation | OTSUKA ICU MEDCL | Prescription | 17 Jan 1986 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | B BRAUN | Prescription | 29 Feb 1988 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | FRESENIUS KABI USA | Prescription | 28 Jan 2019 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | B BRAUN | Discontinued | 21 Feb 1978 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | solution · irrigation | BAXTER HLTHCARE | Discontinued | 29 Aug 1989 |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | MILES | Discontinued | |
| LACTATED RINGER'S IN PLASTIC CONTAINER | 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML | injectable · injection | ABBOTT | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| LACTATED RINGER'S INJECTION | 00039470 | 0.2 MG / ML; 0.3 MG / ML; 3.1 MG / ML; 6 MG / ML | SOLUTION · INTRAVENOUS | ICU MEDICAL CANADA INC |
| LACTATED RINGER'S INJECTION USP | 01931636 | 20 MG / 100 ML; 310 MG / 100 ML; 600 MG / 100 ML; 30 MG / 100 ML | SOLUTION · INTRAVENOUS | B. BRAUN MEDICAL INC |
| LACTATED RINGER'S INJECTION, USP | 00061085 | 600 MG / 100 ML; 30 MG / 100 ML; 20 MG / 100 ML; 310 MG / 100 ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| LACTATED RINGER'S IRRIGATION | 00758566 | 20 MG / 100 ML; 600 MG / 100 ML; 30 MG / 100 ML; 310 MG / 100 ML | SOLUTION · IRRIGATION | ICU MEDICAL CANADA INC |
| LACTATED RINGER'S IRRIGATION SOL | 00799971 | 310 MG / 100 ML; 30 MG / 100 ML; 20 MG / 100 ML; 600 MG / 100 ML | LIQUID · IRRIGATION | BAXTER CORPORATION |
| POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION | 02243421 | 20 MG / 100 ML; 600 MG / 100 ML; 179 MG / 100 ML; 310 MG / 100 ML | LIQUID · INTRAVENOUS | BAXTER CORPORATION |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.